What is Beneficient's discount rate?

Beneficient (BENF) reported discount rate of 20% in Q2 2023.

What does discount rate mean?

The specific percentage rate applied to reduce the nominal value of stock during conversion or liquidity transactions. This rate is a key lever in determining the cost of capital for the company and the effective return for the counterparty. It serves as a measure of the risk premium or liquidity discount inherent in the company's bespoke financial products.

Beneficient BENF Discount rate

Discount rate at other companies

Jaguar Uranium JAGU

25%—

Ondas, Inc. ONDS

19%—

BioSig Technologies, Inc.STEX

40.5%—

CorMedixCRMD

17%—

CorMedixCRMD

17%—

EVI IndustriesEVI

5%0.0pp

Other financials

Income statement

See full

Revenue$18.7M+322%

Operating income$3.9M+141%

Net income$19.9M+331%

EPS (diluted)-$0.49+26.5%

Balance sheet

See full

Cash & equivalents$7.9M+87.3%

Total debt$100.3M-16.6%

Total equity-$128.6M-1,002%

Total assets$337.9M-15.5%

Cash flow

See full

Operating cash flow-$9.4M+6.3%

CapEx$96.0K-85.5%

Free cash flow-$9.4M+6.7%

Valuation

See full

Market cap$52.86M+2,018%

Enterprise value$145.33M+40.6%

Profitability

See full

Operating margin548.5%-323pp

Net margin517.9%-235pp

FCF margin156.8%-40.4pp

Returns & leverage

See full

Return on equity-1,647.1%-2,080pp

Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept ben:ConversionOfStockDiscountRate.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's discount rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beneficient's discount rate?: Beneficient (BENF) reported discount rate of 20% in Q2 2023.
What does discount rate mean?: The specific percentage rate applied to reduce the nominal value of stock during conversion or liquidity transactions. This rate is a key lever in determining the cost of capital for the company and the effective return for the counterparty. It serves as a measure of the risk premium or liquidity discount inherent in the company's bespoke financial products.